Literature DB >> 24920267

Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes.

David Z I Cherney1, Fengxia Xiao, Joseph Zimpelmann, Ronnie L H Har, Vesta Lai, James W Scholey, Heather N Reich, Kevin D Burns.   

Abstract

Angiotensin-converting enzyme 2 (ACE2) is expressed in the kidney and may be renoprotective. We determined whether urinary ACE2 enzyme activity and protein levels (ELISA), as well as angiotensinogen and ACE, are elevated during clamped euglycemia (4-6 mmol·L(-1)) in patients with uncomplicated type 1 diabetes (T1D, n = 58) compared with normoglycemic controls (n = 21). We also measured the effect of clamped hyperglycemia (9-11 mmol·L(-1)) on each urinary factor in T1D patients. Urinary ACE2 activity and protein levels were higher during clamped euglycemia in T1D compared with the controls (p < 0.0001). In contrast, urinary angiotensinogen levels (p = 0.27) and ACE excretion (p = 0.68) did not differ. In response to clamped hyperglycemia in T1D, urinary ACE2 protein decreased (p < 0.0001), whereas urinary ACE2 activity as well as angiotensinogen and ACE levels remained unchanged. Urinary ACE2 activity and protein expression are increased in T1D patients prior to the onset of clinical complications. Further work is required to determine the functional role of urinary ACE2 in early T1D.

Entities:  

Keywords:  ECA2 urinaire; diabetes mellitus; diabète sucré; urinary ACE2

Mesh:

Substances:

Year:  2014        PMID: 24920267     DOI: 10.1139/cjpp-2014-0065

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  11 in total

1.  Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.

Authors:  Sridevi Gutta; Nadja Grobe; Meenasri Kumbaji; Hassan Osman; Mohammad Saklayen; Gengxin Li; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

2.  Excessive Glutamate Stimulation Impairs ACE2 Activity Through ADAM17-Mediated Shedding in Cultured Cortical Neurons.

Authors:  Jiaxi Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Cell Mol Neurobiol       Date:  2018-05-15       Impact factor: 5.046

3.  Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.

Authors:  Elena Velkoska; Sheila K Patel; Karen Griggs; Raelene J Pickering; Chris Tikellis; Louise M Burrell
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 4.  Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.

Authors:  Carole G Campion; Oraly Sanchez-Ferras; Sri N Batchu
Journal:  Can J Kidney Health Dis       Date:  2017-05-22

5.  Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes.

Authors:  Takuo Yoshimoto; Takayuki Furuki; Hiroyuki Kobori; Masaaki Miyakawa; Hitomi Imachi; Koji Murao; Akira Nishiyama
Journal:  J Investig Med       Date:  2017-06-08       Impact factor: 2.895

Review 6.  ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations.

Authors:  Eric M Snyder; Bruce D Johnson
Journal:  Pharmacogenomics       Date:  2020-06-05       Impact factor: 2.533

7.  Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension.

Authors:  Laale F Alawi; Sanjeev Dhakal; Sana E Emberesh; Harshal Sawant; Anhar Hosawi; Unmesha Thanekar; Nadja Grobe; Khalid M Elased
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 8.  Diabetes and COVID-19; A Bidirectional Interplay.

Authors:  Paraskevi Kazakou; Vaia Lambadiari; Ignatios Ikonomidis; Aikaterini Kountouri; Georgios Panagopoulos; Stavros Athanasopoulos; Eleni Korompoki; Ioannis Kalomenidis; Meletios A Dimopoulos; Asimina Mitrakou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-17       Impact factor: 5.555

9.  Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells.

Authors:  Fengxia Xiao; Joseph Zimpelmann; Dylan Burger; Christopher Kennedy; Richard L Hébert; Kevin D Burns
Journal:  Front Pharmacol       Date:  2016-06-01       Impact factor: 5.810

10.  Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.

Authors:  Jiaxi Xu; Srinivas Sriramula; Huijing Xia; Lisa Moreno-Walton; Frank Culicchia; Oliver Domenig; Marko Poglitsch; Eric Lazartigues
Journal:  Circ Res       Date:  2017-05-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.